rAAV Clarification Filtration Without Centrifugation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for large-scale purification of recombinant Adeno-Associated Virus (rAAV) particles are inefficient and require costly centrifugation, leading to significant product loss and inability to remove cells and cell debris effectively.
Innovation Solution
A multi-stage filtration process using depth filters and optional pretreatment with nuclease, salt addition, and pH adjustment to clarify rAAV particles without centrifugation or tangential flow microfiltration, followed by chromatography for isolation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If centrifugation is used to clarify cell culture feed, then cells and cell debris are removed effectively, but the process is time-consuming and requires costly and complicated equipment
Solution Approach 1:
The patent replaces the mechanical centrifugation system with a filtration-based system using depth filters and inert filters. This substitution eliminates the need for costly centrifugation equipment while achieving effective removal of cells and cell debris through sequential filtration stages, directly resolving the contradiction between clarification effectiveness and equipment complexity
Solution Approach 2:
The patent employs depth filters with specific pore size distributions to clarify cell culture feed. The porous structure of the depth filters allows effective separation of cells and debris based on size exclusion, providing a simpler alternative to centrifugation that maintains high clarification effectiveness without requiring complex mechanical equipment
2Loss of substance
If inert filters are used for rAAV purification, then product binding is minimized, but capacity to remove cells and cell debris is insufficient
Solution Approach 1:
The patent divides the filtration process into two distinct stages: first using depth filters for bulk removal of cells and debris (high capacity step), then using inert filters for final clarification (low product binding step). This segmentation allows each filter type to perform its optimal function, resolving the contradiction between clarification capacity and product loss
Solution Approach 2:
The depth filter acts as an intermediary that performs the heavy lifting of cell and debris removal before the rAAV-containing filtrate reaches the inert filter. This intermediate step protects the inert filter from becoming clogged while ensuring effective clarification, thereby maintaining both high productivity and low product loss
3Productivity
If multi-stage filtration is implemented, then clarification capacity increases, but process complexity increases
Solution Approach 1:
The patent combines depth filtration and inert filtration into a single integrated filter train system where filters are connected in series. This merging allows multi-stage clarification to occur in one continuous pass without requiring separate processing steps or complex control systems, thereby increasing clarification capacity while minimizing process complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high yield and purity of rAAV particles, suitable for GMP compliance, with reduced equipment costs and time consumption, applicable to various AAV serotypes.
Implementation Method 1
subjecting the composition to multi-stage filtration... contacting the feed with a primary depth filter to generate a primary filtrate... contacting the primary filtrate with a secondary depth filter to generate a secondary filtrate
Implementation Method 2
treatment with nuclease or endonuclease... treatment with nuclease (e.g., Benzonase®) or endonuclease (e.g., endonuclease from Serratia marcescens)
Implementation Method 3
addition of salt... adding salt to the feed
Implementation Method 4
pH adjustment... pH adjustment, and/or addition of a flocculent
Implementation Method 5
addition of a flocculent... addition of salt, pH adjustment, and/or addition of a flocculent
Implementation Method 6
isolating the rAAV particles from the clarified composition by one or more of tangential flow filtration, affinity chromatography, anion exchange chromatography, hydrophobic interaction chromatography, size exclusion chromatography
Data Source
AI summary
Provided herein are scalable methods for the clarification of a composition comprising recombinant Adeno-Associated Virus (rAAV) particles and an impurity.